| 10980217
|
Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. |
Am J Cardiol |
2000 |
Korkmaz ME;Muderrisoglu H;Ulucam M;Ozin B |
View
More |
| 11401114
|
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. |
J Am Coll Cardiol |
2001 |
Yee KM;Pringle SD;Struthers AD |
View
More |
| 18261010
|
[Effect of long term therapy with spironolactone on parameters of 24-hour heart rhythm variability and ventricular arrhythmias in patients with heart failure receiving optimal therapy]. |
Kardiologiia |
2008 |
Skvortsov AA;Mareev VIu;Orlova IaA;Chelmakina SM;Baklanova NA;Belenkov IuN |
View
More |
| 19104723
|
A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure. |
Cardiovasc J Afr |
2008 |
Shehab A;Elnour AA;Struthers AD |
View
More |
| 22613740
|
Altered cortical activation patterns associated with baroreflex unloading following 24 h of physical deconditioning. |
Exp Physiol |
2012 |
Shoemaker JK;Usselman CW;Rothwell A;Wong SW |
View
More |
| 23279762
|
The blockade of angiotensin AT1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction. |
Acta Physiol (Oxf) |
2013 |
Marques Neto SR;da H Silva A;dos Santos MC;Ferraz EF;Nascimento JH |
View
More |
| 33613861
|
Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial. |
Ups J Med Sci |
2021 |
Eklund M;Hellberg O;Furuland H;Cao Y;Nilsson E |
View
More |
